Ixazomib Active Not Recruiting Phase 3 Trials for Multiple Myeloma (MM) / Autologous Stem Cell Transplant Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02181413A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant